Table 1.
Baseline characteristics of the 43 subjects in the cohort.
| Parameter | Controls | Pre-diabetes | Non-Diabetes | T2D | P-value 3C | P-value 2C |
|---|---|---|---|---|---|---|
| Gender | 7 F/10 M | 4 F/9 M | 11 F/19 M | 4 F/9 M | — | — |
| Age | 59 ± 10 | 64 ± 8 | 61 ± 9 | 65 ± 7 | 0.2124 | 0.3013 |
| BMI | 26.5 ± 3.8 | 27.6 ± 5.6 | 27.0 ± 4.6 | 27.9 ± 5.6 | 0.8417 | 1 |
| HbA1c | 36.2 ± 1.9 | 40.8 ± 1.8 | 38.2 ± 2.9 | 56.5 ± 15.5 | 1.6 × 10−8 | 6.9 × 10−7 |
| GSIS | 11.8 ± 5.6 | 15.1 ± 30.8 | 13.2 ± 20.3 | 5.0 ± 2.5 | 1.3 × 10−3 | 2.6 × 10−3 |
The mean value and the standard deviation are shown for age, BMI, HbA1c and GSIS. Gender is shown as the proportion of females (F) and males (M). Age is expressed in years. BMI is in kg/m2. HbA1c is in % of mmol/mol. GSIS is mmol in liters of glucose. Non-diabetes is the merged group of controls and pre-diabetes. P-value 3C is calculated from a Kruskal-Wallis test on controls, pre-diabetes and T2D. P-value 2C is calculated from a Mann-Whitney U test on non-diabetes and T2D.